---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-26-000037"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2026-05-26T13:03:51+00:00"
generated_at: "2026-05-26T13:06:01.515470+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health enters collaboration with Cleveland Clinic for AI-powered diagnostics

## Summary
- Partnering fee of $125,000; $50,000 due within 30 days, then $25,000 on each of first three anniversaries.
- Collaboration focuses on biomarker discovery, AI-driven modeling, and clinical validation for women's health diagnostics.
- Joint leadership: Dr. Kevin Elias (Cleveland Clinic) and Dr. Todd Pappas (Aspira) will lead multidisciplinary teams.
- Initial five-year term; may be extended by mutual agreement; either party can terminate with 60 days' notice.

## SEC filing metadata
- accession: 0000926617-26-000037
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2026-05-26T13:03:51+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/0000926617-26-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/awhl-20260520x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-26-000037
- JSON: https://secwatch.observer/filing/0000926617-26-000037.json
- Plain text: https://secwatch.observer/filing/0000926617-26-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.